Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trialAndrew R. Clamp, Jonathan A. Ledermann, C.L. Hanna et al.|The Lancet Oncology|2022Cited by 45
805O ICON8: Overall survival results in a GCIG phase III randomised controlled trial of weekly dose-dense chemotherapy in first line epithelial ovarian, fallopian tube or primary peritoneal carcinoma treatmentAndrew R. Clamp, Jonathan A. Ledermann, Timothy Perren et al.|Annals of Oncology|2020Cited by 4